British Association of Dermatologists Guidelines for the Management of People With Rosacea 2021

P.J. Hampton; J. Berth-Jones; C.E. Duarte Williamson; R. Hay; T.A. Leslie; I. Porter; S. Rauz; D. Seukeran; R.T. Winn; M. Hashme; L.S. Exton; M.F. Mohd Mustapa; L. Manounah

Disclosures

The British Journal of Dermatology. 2021;185(4):725-735.

Purpose and Scope

The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of rosacea. The document aims to: (i) offer an appraisal of all relevant literature up to February 2020 focusing on any key developments; (ii) address important, practical clinical questions relating to the primary guideline objective; and (iii) provide guideline recommendations and, if appropriate, research recommendations.

The guideline is presented as a detailed review with highlighted recommendations for practical use in primary care and in the clinic, in addition to an updated Patient Information Leaflet [available on the British Association of Dermatologists' (BAD) website: www.skinhealthinfo.org.uk/a-z-conditions-treatments/].

Exclusions

This guideline does not cover the diagnosis of rosacea. The evidence supporting the recommendations does not include evidence that is specific to children.

1 2 3 4 5 6 7 8 9

Next Section

Table 1. Strength of recommendation ratings
Strength	Wording	Symbols	Definition
Strong recommendation for the use of an intervention	'Offer' (or similar, e.g. 'use', 'provide', 'take', 'investigate', etc.)	↑↑	Benefits of the intervention outweigh the risks; most patients would choose the intervention, while only a small proportion would not; for clinicians, most of their patients would receive the intervention; for policy makers, it would be a useful performance indicator
Weak recommendation for the use of an intervention	'Consider'	↑	Risks and benefits of the intervention are finely balanced; most patients would choose the intervention but many would not; clinicians would need to consider the pros and cons for the patient in the context of the evidence; for policy makers it would be a poor performance indicator where variability in practice is expected
No recommendation		Θ	Insufficient evidence to support any recommendation
Strong recommendation against the use of an intervention	'Do not offer'	↓↓	Risks of the intervention outweigh the benefits; most patients would not choose the intervention, while only a small proportion would; for clinicians, most of their patients would not receive the intervention